A study to test how well different doses of BI 3821001 are tolerated by healthy people
Before any new medicine can be given to patients with specific illnesses, scientists must first check that it is safe to use. This Phase 1 study tests a new trial drug called BI 3821001 in healthy adult volunteers. The main goal is to see how well the body tolerates different amounts of the medicine and to monitor for any unwanted side effects. Researchers will also look at how the drug travels through the body, how quickly it breaks down, and how it is cleared away. Taking part involves visiting a specialist clinical research unit. Staff will carry out regular health checks, such as blood tests, heart tracings, and blood pressure readings. Because this is an early safety study, volunteers do not receive any personal health benefit from the medicine, but their involvement provides vital information to help develop potential treatments for the future.
At a glance
What is this study about?
Every new medicine must go through careful checks before it can be used in hospitals and clinics. This clinical trial is an early step, known as a Phase 1 study. Its main purpose is to test an experimental drug named BI 3821001 in healthy human volunteers. Researchers want to see how safe the drug is when given at different doses and whether it causes any uncomfortable or unexpected side effects.
In studies like this, small groups of people are usually given a low dose first. Doctors closely watch how their bodies respond. If the medicine proves safe and gentle on the body, doctors may test slightly higher doses in new groups. This step-by-step process helps medical teams discover what a sensible, safe dose might be for future trials involving patients who are unwell.
The study also tracks what is known as 'pharmacology'. This means measuring how the body absorbs the medicine, how it moves through the bloodstream, and how the liver and kidneys remove it over time. Understanding these basic processes ensures that any future treatments can be planned with the highest possible level of care.
By taking part, healthy volunteers help scientists answer these essential questions. Although the drug is not designed to treat a condition the volunteers have, their time and support lay the groundwork for developing new therapies that could one day help many people.
Key takeaways
- This is an early-stage Phase 1 safety study testing the trial medicine BI 3821001.
- The study is designed for healthy adult volunteers aged 18 and older.
- The main purpose is to check how safe different doses are and watch for side effects.
- Volunteers will be closely monitored with health checks and blood tests.
- Taking part is voluntary, and you can stop your participation at any time.
Who may be eligible?
This study is aimed at healthy adults aged 18 and over. Because researchers need to see how the new medicine acts on a healthy body, volunteers should generally be in good overall physical and mental health.
You are unlikely to be able to take part if you have a long-term medical illness, such as heart disease, kidney problems, severe asthma, or high blood pressure. Taking regular prescription medications, over-the-counter tablets, or herbal supplements might also mean you cannot join, as these could interfere with the study results.
Women who are pregnant, planning a pregnancy, or breastfeeding are usually not eligible to join Phase 1 safety trials. The study doctor will run full health checks and discuss your medical history before deciding whether it is safe for you to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 18 or older.
- I consider myself to be in good general health.
- I do not have major long-term illnesses like heart, liver, or kidney problems.
- I am not taking regular prescription medications.
- I am not currently pregnant or breastfeeding.
- I am able and willing to attend appointments at the research clinic.
What does participation involve?
If you decide to take part, you will first attend a screening visit. The trial team will explain everything clearly, take blood and urine samples, check your heart with an ECG (electrocardiogram), and measure your blood pressure. Once accepted, you will be given a specific dose of BI 3821001 at a dedicated clinical research clinic. This may involve staying overnight at the unit or coming in for several daytime visits so the team can monitor you closely. Staff will repeat routine tests, take regular blood samples to see how much medicine is in your blood, and ask how you are feeling. After you finish taking the medicine, there will be a follow-up visit or phone call to check on your recovery. The total time you are involved will be explained by the study team before you agree to join.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What is a Phase 1 clinical trial?
A Phase 1 trial is one of the very first times a new medicine is tested in people. It focuses mainly on safety, dose levels, and side effects rather than treating an illness.
Will I be paid for taking part?
Healthy volunteer trials often offer payment or compensation to cover your time, travel expenses, and any inconvenience. The study team can give you full details.
Can I leave the study if I change my mind?
Yes. Taking part is completely voluntary. You can withdraw your consent at any time without having to give an explanation.
What happens if I experience side effects?
You will be looked after by trained doctors and nurses who will treat any symptoms quickly. Emergency medical equipment and support are always on hand.
Do I need to tell my own GP?
Yes. It is standard practice to inform your GP that you are joining a clinical study so they can keep your medical records up to date.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.